Cartesian Therapeutics CVR
13F holders, Q4 2025 (December 31)4holders +1
0new positions
0sold out
$0.03avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, up 1 from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Sterling Capital Management LLC ($6K), Ironwood Investment Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 4 holders
| Sterling Capital Management LLC | 0.00% | No change | 8,268 | $6K |
| Ironwood Investment Management LLC | 0.00% | No change | 170,087 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 237 | $0 |
| Cygnus Capital Advisors, LLC | 0.00% | — | 951 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.